Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Alfa Financial Software H1 revenues up 20pc, maintains FY guidance

(Sharecast News) - Finance industry software developer Alfa Financial Software said on Thursday that its first-half trading performance was in line with expectations, putting the group on track to meet full-year expectations. Alfa Financial said total revenues were up 20% in the six months ended 30 June at £62.5m, while annual recurring revenues rose 16% at £41.6m, with a net revenue retention rate of 112%. Pre-tax profits rose 34% to £21.5m and earnings per share increased by 33% to 5.38p.

The FTSE 250-listed firm highlighted that it had seen "very strong" software engineering revenues in H1, up 72% year-on-year, driving high first-half operating profit margins of 35%. Total contract value increased 9% to £211m, driven by ongoing growth in subscription revenues.

Alfa Financial also declared a special dividend of 5p per share, reflecting "sustained strong growth" in cash generation and continued capital allocation discipline.

Looking forward, Alfa said the "exceptionally strong conversion of wins in 2024" had resulted in a step up to a record level of total contract values at the prior year's end, creating "an excellent foundation" for continued long-term growth.

"The very strong performance in the first half of the year was driven by an expected large increase in software engineering revenues. In the second half of the year, we expect a lower level of software engineering revenues and an impact from planned increases in headcount investment and salary costs," said Alfa.

"Ongoing work with customers, including those in the late-stage pipeline, means we remain confident in our full-year expectations, despite currency headwinds and wider macro uncertainty. We continue to be well-positioned for further progress and remain focused on delivering value in 2025 and beyond."

As of 1020 BST, Alfa Financial shares were up 0.023% at 217.55p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.